Resolute Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Sell |
57,526
-4,050
| -7% | -$13.9K | 0.05% | 64 |
|
|
2025
Q1 | $137K | Hold |
61,576
| – | – | 0.04% | 60 |
|
|
2024
Q4 | $180K | Hold |
61,576
| – | – | 0.04% | 75 |
|
|
2024
Q3 | $160K | Buy |
61,576
+4,050
| +7% | +$10.5K | 0.03% | 54 |
|
|
2024
Q2 | $170K | Hold |
57,526
| – | – | 0.04% | 47 |
|
|
2024
Q1 | $261K | Hold |
57,526
| – | – | 0.05% | 43 |
|
|
2023
Q4 | $328K | Hold |
57,526
| – | – | 0.04% | 46 |
|
|
2023
Q3 | $265K | Hold |
57,526
| – | – | 0.04% | 45 |
|
|
2023
Q2 | $372K | Hold |
57,526
| – | – | 0.04% | 44 |
|
|
2023
Q1 | $434K | Hold |
57,526
| – | – | 0.05% | 37 |
|
|
2022
Q4 | $583K | Hold |
57,526
| – | – | 0.08% | 26 |
|
|
2022
Q3 | $569K | Hold |
57,526
| – | – | 0.07% | 25 |
|
|
2022
Q2 | $613K | Buy |
57,526
+14,086
| +32% | +$150K | 0.06% | 27 |
|
|
2022
Q1 | $424K | Hold |
43,440
| – | – | 0.02% | 45 |
|
|
2021
Q4 | $621K | Hold |
43,440
| – | – | 0.02% | 37 |
|
|
2021
Q3 | $871K | Buy |
+43,440
| New | +$871K | 0.12% | 32 |
|